0001104659-21-095084.txt : 20210722 0001104659-21-095084.hdr.sgml : 20210722 20210722210105 ACCESSION NUMBER: 0001104659-21-095084 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210720 FILED AS OF DATE: 20210722 DATE AS OF CHANGE: 20210722 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Esposito Pamela CENTRAL INDEX KEY: 0001744425 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 211108866 MAIL ADDRESS: STREET 1: C/O REPLIMUNE GROUP, INC. STREET 2: 18 COMMERCE WAY CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822082553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (781) 222-9600 MAIL ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 4 1 tm2123078-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-07-20 0 0001737953 Replimune Group, Inc. REPL 0001744425 Esposito Pamela C/O REPLIMUNE GROUP, INC., 500 UNICORN PARK WOBURN MA 01801 0 1 0 0 Chief Business Officer Common Stock 2021-07-20 4 M 0 4862 1.01 A 215021 D Common Stock 2021-07-20 4 S 0 4862 33.05 D 210159 D Common Stock 2021-07-21 4 M 0 12538 1.01 A 222697 D Common Stock 2021-07-21 4 S 0 12538 33.17 D 210159 D Employee Stock Option (right to buy) 1.01 2021-07-20 4 M 0 4862 0 D 2025-11-01 Common Stock 4862 63741 D Employee Stock Option (right to buy) 1.01 2021-07-21 4 M 0 12538 0 D 2025-11-01 Common Stock 12538 51203 D The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. Following the sales reported on this Form 4, the reporting person continues to beneficially own 210,159 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 488,102 shares of the Issuer's common stock, 324,649 of which are exercisable as of the date hereof. Due to scrivener's error, footnote 2 of the Form 4 filed on behalf of the reporting person on July 19, 2021 inadvertently overstated the number of options held by the Reporting Person following the transaction reported therein. The amounts stated in this footnote 2 set forth the correct number of options held by the Reporting Person following the transaction reported herein. The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof. /s/ Jean Franchi, attorney-in-fact 2021-07-22